Results 151 to 160 of about 45,210 (266)

High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 10, October 2026.
ABSTRACT Purpose This study aims to assess the risk of metabolic side effects among paediatric new users of antipsychotics in Sweden, focusing on differences between substances and sexes. Methods Children aged 5–17 years, who were new users of antipsychotics between 2014 and 2021, were identified using Swedish national health registers.
Elin Eyfells Kimland, Anders Sundström, Sverre Wikström, Håkan Jarbin, Elin Dahlén   +4 more
wiley   +1 more source

Utility of clozapine trough level reporting in clinical practice: A four-year retrospective evaluation from India. [PDF]

Indian J Psychiatry
Patil AN, Khatri P, Sharma S, Pattanaik S, Chakrabarti S, Charan YD, Singh N, Kashyap A, Grover S.   +8 more
europepmc   +1 more source

Updated Estimates of Agreement Between Dispensed Medications and Forensic Toxicology in Sweden

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 10, October 2026.
ABSTRACT Purpose To present updated estimates from a nationwide Swedish study comparing dispensed medications with forensic toxicological findings (2006–2013), following re‐evaluation of the toxicology dataset to address periods with non‐uniform analytical detection and inconsistent testing.
Heidi Taipale, Jari Tiihonen, Antti Tanskanen, Jonas Forsman   +3 more
wiley   +1 more source

Investigation of the Gut Microbiome in Treatment-Resistant Schizophrenia Compared to Healthy Controls: A Cross-Sectional Pilot Study: Étude du microbiome intestinal chez les patients atteints de schizophrénie résistante au traitement par rapport aux témoins sains : étude pilote transversale. [PDF]

Can J Psychiatry
Liu JCW, Gorbovskaya I, Zhang AY, Hahn MK, De Palma G, Müller DJ.   +5 more
europepmc   +1 more source

Clozapine is underutilized.

Shanghai archives of psychiatry, 2012
openaire   +2 more sources

Mechanism‐Informed Pharmacotherapy Optimization and Deprescribing: A Redox–Mitochondrial Framework

Pharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
From cumulative drug burden to mitochondrial stress and functional decline. The graphical abstract summarizes the central concept of the review, illustrating how cumulative pharmacotherapy exposure may contribute to redox–mitochondrial stress and thereby reduce biological and functional resilience.
Boštjan Martinc
wiley   +1 more source

Health-Related Quality of Life Among Patients with Treatment-Resistant Schizophrenia Receiving Clozapine-Based Therapy in South Kalimantan, Indonesia. [PDF]

Patient Prefer Adherence
Erlianti K, Alfaqeeh M, Puspitasari IM, Purba FD, Suwantika AA.   +4 more
europepmc   +1 more source

A cortical pathway to sleep: Role of long‐range inhibition

Clinical and Translational Medicine, Volume 16, Issue 10, October 2026.
Geoffrey Terral, Renata Batista‐Brito
wiley   +1 more source

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

Acta Psychiatrica Scandinavica, Volume 154, Issue 4, Page 277-285, October 2026.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark, Mussie Msghina, Axel Nordenskjöld   +2 more
wiley   +1 more source

Clozapine-Induced Gastrointestinal Hypoperfusion Leading to Bowel Ischemia and Secondary Atrial Fibrillation: A Case Report. [PDF]

Case Rep Psychiatry
Kumar S, Chatterjee M.
europepmc   +1 more source